Medial EarlySign focuses on identifying those individuals with ‘rising risk’ in the population who are most likely to become tomorrow’s high-burden patients, in time for preventative action to be taken. This 5% of the population will eventually account for 50% of healthcare costs.
We are currently at various stages of developing dozens of AlgoMarkers™ – our predictive risk engines for a variety of healthcare outcomes. Our research ranges from the early prediction of cancers to personalized and outcome-based interpretation of lab results, flagging diabetics who are ‘at risk’ for nephropathy, data-driven risk tools for inpatients, and many other areas.
Contact us today to learn more.